闭合切口负压治疗减少DIEP皮瓣乳房再造供区手术创面裂开:一项随机临床试验
这项随机临床试验纳入80例符合条件的女性,按低危或高危分层,随机接受闭合切口负压治疗或胶条处理,主要结局为随访12周时腹部供区手术创面裂开和手术部位感染。75例完成研究,供区手术创面裂开发生于23例,绝对风险降低有统计学意义(21.6%,95%CI 1.5%至41.7%)。结论认为闭合切口负压治疗降低了低危和高危DIEP皮瓣乳房再造患者腹部供区手术创面裂开的发生率。
要点
- 闭合切口负压治疗组供区手术创面裂开绝对风险降低21.6%(95%CI 1.5%至41.7%),有统计学意义。
- 手术部位感染和次要结局(血清肿、血肿)未见统计学显著差异。
- 证据等级为治疗性,I级。
核心结论
- 在这项随机临床试验中,术后闭合切口负压治疗降低了低危和高危DIEP皮瓣乳房再造患者腹部供区手术创面裂开的发生率。
研究设计与样本
- 随机临床试验,纳入80例符合条件的女性,按低危或高危分层,通过抽取密封不透明信封随机分配至闭合切口负压治疗或胶条处理,所有外科医生对分组保持盲法。
- 主要结局为随访12周时腹部供区手术创面裂开和手术部位感染,次要结局为血清肿和血肿形成。
- 5例因研究治疗暴露不足(n=4)或重大方案偏离(n=1)被排除,最终75例低危(n=38)和高危(n=37)患者接受闭合切口负压治疗(n=36)或胶条处理(n=39)。
主要发现
- 供区手术创面裂开发生于23例患者,绝对风险降低有统计学意义(21.6%,95%CI 1.5%至41.7%)。
- 手术部位感染或次要结局未见统计学显著差异。
- 患者人口学特征无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In breast reconstruction operations, surgical wound dehiscence is a serious complication that generates a significant burden on patients and health care systems. There are indications that postoperative treatment with closed-incision negative-pressure therapy has been associated with reduced wound dehiscence rates. This randomized clinical trial examines the effect of closed-incision negative-pressure application on abdominal donor-site surgical wound dehiscence in low- and high-risk patients undergoing breast reconstruction with a deep inferior epigastric perforator flap. METHODS: Eighty eligible women, stratified as low- or high-risk patients, were included and were randomized for treatment with either closed-incision negative-pressure or adhesive strips by drawing sealed, opaque envelopes. All surgeons were kept blinded for allocation. Primary outcomes were surgical wound dehiscence and surgical-site infection at the abdominal donor site on follow-up after 12 weeks. Secondary outcomes were seroma and hematoma formation. Five patients were excluded from the study because of insufficient exposure to the study treatment ( n = 4) or major protocol deviation ( n = 1). RESULTS: A total of 75 women, low-risk ( n = 38) and high-risk ( n = 37), received either closed-incision negative-pressure ( n = 36) or adhesive strips ( n = 39). Patients' demographics did not differ significantly. Donor-site surgical wound dehiscence occurred in 23 patients; the absolute risk reduction was statistically significant (21.6 percent; 95 percent CI, 1.5 to 41.7 percent). No statistically significant differences were found in surgical-site infection or secondary outcomes. CONCLUSION: In this randomized clinical trial, postoperative treatment with closed-incision negative-pressure therapy decreased the incidence of surgical wound dehiscence at the abdominal donor site in low- and high-risk deep inferior epigastric perforator flap breast reconstruction patients. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, I.
引用
- Muller-Sloof E, de Laat E, Kenç O, et al. Closed-Incision Negative-Pressure Therapy Reduces Donor-Site Surgical Wound Dehiscence in DIEP Flap Breast Reconstructions: A Randomized Clinical Trial. Plast Reconstr Surg. 2022. PMID: 35943913. doi:10.1097/PRS.0000000000009541
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。